Veeva Systems Inc. $VEEV Stake Increased by Motley Fool Asset Management LLC

Motley Fool Asset Management LLC grew its holdings in Veeva Systems Inc. (NYSE:VEEV) by 364.0% in the third quarter, HoldingsChannel.com reports. The institutional investor owned 11,220 shares of the technology company’s stock after buying an additional 8,802 shares during the quarter. Motley Fool Asset Management LLC’s holdings in Veeva Systems were worth $3,203,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Principal Financial Group Inc. raised its holdings in shares of Veeva Systems by 7.0% in the first quarter. Principal Financial Group Inc. now owns 4,141,545 shares of the technology company’s stock valued at $727,513,000 after buying an additional 271,252 shares during the last quarter. Swedbank AB grew its holdings in Veeva Systems by 43.5% during the 1st quarter. Swedbank AB now owns 1,645,128 shares of the technology company’s stock worth $288,983,000 after acquiring an additional 498,971 shares during the last quarter. Amundi grew its holdings in Veeva Systems by 8.0% during the 1st quarter. Amundi now owns 992,977 shares of the technology company’s stock worth $174,426,000 after acquiring an additional 73,510 shares during the last quarter. Arrowstreet Capital Limited Partnership grew its holdings in Veeva Systems by 203.0% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 913,281 shares of the technology company’s stock worth $160,427,000 after acquiring an additional 611,868 shares during the last quarter. Finally, Royal Bank of Canada increased its position in Veeva Systems by 2.7% in the 1st quarter. Royal Bank of Canada now owns 870,281 shares of the technology company’s stock valued at $152,873,000 after acquiring an additional 23,117 shares in the last quarter. 88.20% of the stock is currently owned by institutional investors and hedge funds.

Veeva Systems Stock Down 2.4%

Veeva Systems stock opened at $310.24 on Friday. The business’s 50-day simple moving average is $282.72 and its 200 day simple moving average is $209.39. The stock has a market cap of $50.23 billion, a price-to-earnings ratio of 51.34, a P/E/G ratio of 1.36 and a beta of 0.93. Veeva Systems Inc. has a 12-month low of $148.05 and a 12-month high of $325.99.

Veeva Systems (NYSE:VEEV) last issued its earnings results on Wednesday, August 26th. The technology company reported $2.35 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.23 by $0.12. Veeva Systems had a net margin of 29.34% and a return on equity of 14.25%. The company had revenue of $927.96 million for the quarter, compared to analyst estimates of $905.38 million. During the same quarter last year, the firm earned $1.99 EPS. The company’s revenue for the quarter was up 17.6% on a year-over-year basis. Veeva Systems has set its FY 2027 guidance at 9.210-9.210 EPS and its Q3 2027 guidance at 2.330-2.340 EPS. As a group, sell-side analysts expect that Veeva Systems Inc. will post 6.70 EPS for the current year.

Insider Buying and Selling at Veeva Systems

In other Veeva Systems news, insider Thomas D. Schwenger sold 10,000 shares of Veeva Systems stock in a transaction on Thursday, August 27th. The shares were sold at an average price of $281.33, for a total transaction of $2,813,300.00. Following the completion of the sale, the insider owned 19,449 shares of the company’s stock, valued at approximately $5,471,587.17. The trade was a 33.96% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Daniel J. Rizzo sold 4,841 shares of Veeva Systems stock in a transaction on Friday, October 2nd. The stock was sold at an average price of $276.51, for a total transaction of $1,338,584.91. Following the sale, the executive vice president directly owned 7,665 shares of the company’s stock, valued at $2,119,449.15. This represents a 38.71% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last three months, insiders sold 56,789 shares of company stock valued at $14,913,889. 10.60% of the stock is currently owned by corporate insiders.

Key Headlines Impacting Veeva Systems

Here are the key news stories impacting Veeva Systems this week:

• Positive Sentiment: AI adoption remains a major growth catalyst. At its Commercial Summit Europe, Veeva highlighted AI-driven CRM, conversational tools, Commercial Cloud and Data Cloud innovations designed to improve healthcare-professional engagement, content approval and medical decision-making. Customer examples from AstraZeneca, Bristol Myers Squibb and Roche support the potential for broader adoption among large biopharmaceutical companies. AI CRM Adoption Could Be A Key Catalyst For Veeva Systems Stock
• Positive Sentiment: Analysts continue to raise their valuation expectations. Barclays lifted its price target to $375 from $360 and maintained an overweight rating, while Mizuho raised its target to $345 from $280. These moves signal confidence in Veeva’s growth outlook and AI-enabled product strategy. Barclays Price Target Increase Mizuho Price Target Increase
• Positive Sentiment: Investors are positioned for continued earnings growth. Analysts expect double-digit growth in the upcoming fiscal Q3 2027 report, while Veeva’s latest reported quarter exceeded consensus estimates for both revenue and earnings. What to Expect From Veeva Systems Q3 2027 Earnings Report
• Neutral Sentiment: Valuation is creating a debate. Veeva has recently generated strong momentum, but its high earnings multiple means the stock may be sensitive to guidance, margins and the pace of AI monetization in the upcoming results.
• Negative Sentiment: Recent gains may be prompting profit-taking. With shares near their 52-week high after substantial one- and three-month advances, investors may be locking in gains ahead of earnings, particularly if expectations for AI-driven growth are already reflected in the valuation. Veeva Systems Heads Into Q3 Results

Analyst Upgrades and Downgrades

A number of brokerages have weighed in on VEEV. Needham & Company LLC boosted their target price on shares of Veeva Systems from $270.00 to $310.00 and gave the stock a “buy” rating in a research note on Thursday, August 27th. Robert W. Baird upped their target price on shares of Veeva Systems from $300.00 to $350.00 and gave the stock an “outperform” rating in a research report on Monday. Wall Street Zen raised shares of Veeva Systems from a “hold” rating to a “buy” rating in a research note on Saturday, October 10th. Weiss Ratings raised shares of Veeva Systems from a “hold (c)” rating to a “hold (c+)” rating in a report on Thursday, October 8th. Finally, Canaccord Genuity Group raised their price target on shares of Veeva Systems from $220.00 to $260.00 and gave the company a “hold” rating in a report on Thursday, August 27th. Nineteen research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, Veeva Systems presently has an average rating of “Moderate Buy” and a consensus target price of $293.21.

Veeva Systems Profile

Veeva Systems Inc is a cloud software company that develops technology for the life sciences industry. Its customers include pharmaceutical, biotechnology, medical device and other healthcare companies that use Veeva’s applications to manage commercial, clinical, regulatory, quality and operational processes.

The company’s Veeva Vault platform provides cloud applications for areas such as clinical data management, electronic trial management, regulatory information, quality management, safety and content management.